- Home
- PRAX vs CHDN Comparison
PRAX vs CHDN Comparison
Compare PRAX & CHDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRAX | CHDN |
|---|---|---|
| Founded | 2015 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 7.9B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PRAX | CHDN |
|---|---|---|
| Price | $309.22 | $85.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | ★ $572.13 | $135.60 |
| AVG Volume (30 Days) | 328.9K | ★ 1.0M |
| Earning Date | 05-12-2026 | 05-29-2026 |
| Dividend Yield | N/A | ★ 0.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.49 |
| Revenue | N/A | ★ $1,809,800,000.00 |
| Revenue This Year | N/A | $5.61 |
| Revenue Next Year | $6,395.88 | $3.56 |
| P/E Ratio | ★ N/A | $15.28 |
| Revenue Growth | N/A | ★ 13.31 |
| 52 Week Low | $26.70 | $81.66 |
| 52 Week High | $354.87 | $118.46 |
Technical Indicators
Market Signals| Indicator | PRAX | CHDN |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 36.64 |
| Support Level | $290.36 | N/A |
| Resistance Level | $322.32 | $105.84 |
| Average True Range (ATR) | 17.43 | 3.84 |
| MACD | -4.97 | -0.44 |
| Stochastic Oscillator | 19.48 | 26.09 |
Price Performance
Historical ComparisonAbout PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
About CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.